Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus intravenous high-dose methylprednisolone for multiple sclerosis relapses
2007-000888-15Phase 4Active
- Sponsor
- Servicio de Neurología
- Start
- Feb 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylprednisolone in multiple sclerosis (MS) (2 arms), sponsored by Servicio de Neurología. Primary endpoint: Primary clinical and radiological change from baseline to day 28. Started Feb 2008; status: active.
02
Drugs
methylprednisolone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2007-000888-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000888-15.